Alpha-1 antitrypsin augmentation therapy for acute lung injury

Ended Project Grant Awarded Last action

Award ID
W81XWH2010095
Recipient
Awarding agency
Obligated
$198,669

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Ireland

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Alpha-1 antitrypsin augmentation therapy for acute lung injury. The purpose of this modification is to deobligate the awarded funds for this project in the… -$1,059
Amendment Alpha-1 antitrypsin augmentation therapy for acute lung injury. 1. Updates division i items a.4, a.5.II, a.6, a.7 and a.10.v.2. The final report will become… $0
Amendment Alpha-1 antitrypsin augmentation therapy for acute lung injury extend the period of performance 1. Per section 711 of the national defense authorization act… $0
Amendment Covid-19 alpha-1 antitrypsin augmentation therapy for acute lung injury extend the period of performance $0
Original award $199,728

Quick answers

Who received award W81XWH2010095?

W81XWH2010095 was awarded to Royal College Of Surgeons In Ireland by Defense Health Agency (Department of Defense) on February 15, 2020.

How much is award W81XWH2010095 worth?

$198,669 has been obligated on W81XWH2010095.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login